A study for a 60 year old woman who takes Osphena - from FDA reports


Summary

456 females aged 60 (±5) who take the same drug are studied. This is a personalized study for a 60 year old female patient who has Uterine Atrophy. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

456 females aged 60 (±5) who take Osphena are studied.


Number of reports submitted per year:

Osphena for a 60-year old woman.

Information of the patient in this study:

  • Age: 60
  • Gender: female
  • Conditions: Uterine Atrophy
  • Drugs taken:
    • Osphena (ospemifene)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • rashes
  • headache
  • muscle spasms
  • vaginal discharge
  • nausea
  • hot flush
  • vaginal haemorrhage
  • dizziness
  • fatigue
  • swelling face
1 - 6 months:
  • hot flush
  • vaginal discharge
  • hyperhidrosis
  • vaginal haemorrhage
  • muscle spasms
  • rashes
  • headache
  • pain in extremity
  • drug ineffective
  • therapeutic response unexpected
6 - 12 months:
  • vaginal discharge
  • hyperhidrosis
  • vision blurred
  • hot flush
  • thrombosis
  • asthenopia
  • tinnitus
  • insomnia
  • fall
  • influenza like illness
1 - 2 years:
  • therapeutic response unexpected
  • deep venous thrombosis
  • pulmonary embolism
  • vaginal haemorrhage
  • nausea
  • heart injury
  • endometriosis
  • blood oestrogen decreased
  • abdominal pain lower
  • sex hormone binding globulin increased
2 - 5 years:
  • uterine polyp
  • uterine spasm
  • vaginal haemorrhage
  • oedema peripheral
  • postmenopausal haemorrhage
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • hot flush
  • vaginal discharge
  • muscle spasms
  • rashes
  • headache
  • hyperhidrosis
  • vaginal haemorrhage
  • therapeutic response unexpected
  • insomnia
  • drug ineffective

Top conditions involved for these people *:

  • Sexual Intercourse - Painful (209 people, 45.83%)
  • Vulvovaginal Dryness (75 people, 16.45%)
  • Atrophic Vulvovaginitis (57 people, 12.50%)
  • High Blood Pressure (27 people, 5.92%)
  • High Blood Cholesterol (23 people, 5.04%)

Top co-used drugs for these people *:

  • Synthroid (39 people, 8.55%)
  • Calcium (28 people, 6.14%)
  • Estrace (20 people, 4.39%)
  • Fish Oil (17 people, 3.73%)
  • Zyrtec (15 people, 3.29%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

You may be interested in these reviews

More reviews for: Uterine atrophy, Osphena